Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It focuses on harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. The company was founded by Marcela Maus and Hiromitsu Nakauchi in 2018 and is headquartered in Philadelphia, PA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
78
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Century Therapeutics Inc market cap is $211.56M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Century Therapeutics Inc 52 week high is $3.04 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Century Therapeutics Inc 52 week low is $0.48 as of November 22, 2026.
Century Therapeutics Inc stock price today is $1.17.
Century Therapeutics Inc stock price yesterday was $1.32.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Century Therapeutics Inc's P/E ratio is -1.9.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Century Therapeutics Inc P/B ratio is 1.0056.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Century Therapeutics Inc 50-day moving average is $1.58.